Citadel Advisors
MIRA icon

Citadel Advisors’s MIRA Pharmaceuticals MIRA Stock Holding History

Citadel Advisors’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-97,976
Closed -$112K – 15166
2024
Q4 		$112K Buy
+97,976
New +$128K ﹤0.01% 11303
2024
Q3 		– Sell
-24,396
Closed -$16.1K – 14848
2024
Q2 		$16.1K Buy
+24,396
New +$20K ﹤0.01% 12801

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

Citadel Advisors's MIRA Position: Q1 2025 in Review

Citadel Advisors sold out of MIRA Pharmaceuticals (MIRA) in Q1 2025, closing a stake of 97,976 shares — an estimated $112K sold.

Citadel Advisors first reported a position in MIRA in Q2 2024 and held it in 2 quarters. The position peaked at $112K in Q4 2024. 19 funds tracked by Wall St. Rank hold MIRA as of Q1 2025.

  • Citadel Advisors reported no remaining MIRA Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 97,976 MIRA Pharmaceuticals shares in Q1 2025, an estimated $112K.
  • Citadel Advisors first reported a position in MIRA Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • Citadel Advisors's MIRA Pharmaceuticals position peaked at $112K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.